Monthly Communication Report

Registrant name:	WILLIAM MANTEL
Client:	Centre for the Commercialization of Regenerative Medicine/Centre de commercialisation de la médecine régénérative
Associated registration:	944505-367602-11
Communication date:	2025-02-28
Posted date:	2025-03-15

Designated Public Office Holders who participated in the communication:	Nicholas Kang, Senior Policy Advisor Policy and Cabinet Affairs, Prime Minister's Office (PMO)
List of Details Subject matter Detail Economic Development, Employment and Training, Health, Regional Development, Research and Development, Science and Technology Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products.